1. Symjepi, an epinephrine injector manufactured by Sandoz, was approved for the treatment of severe allergic reactions in children.
2. Eli Lilly & Co. received approval for its preventive migraine treatment Emgality. It is a monthly, self-administered injection.
3. Eluvia drug-eluting vascular stent, manufactured by Boston Scientific, slowly releases the drug paclitaxel to prevent tissue regrowth for the treatment of peripheral artery disease.
4. Leica Microsystem’s Augmented Reality Glow800 surgical florescence was approved for vascular neurosurgery. The florescence allows surgeons to observe cerebral anatomy in natural color.
More articles on supply chain:
Apple Watch: FDA-cleared for electrocardiogram screening
FDA scolds pharmaceutical lab for operating microbrewery in drug testing space
Amazon, Merck, Accenture to launch data-driven drug development platform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
